Clinical Trials Logo

Recurrent Chronic Hepatitis C Virus clinical trials

View clinical trials related to Recurrent Chronic Hepatitis C Virus.

Filter by:
  • None
  • Page 1

NCT ID: NCT01687270 Completed - Clinical trials for Recurrent Chronic Hepatitis C Virus

Safety and Efficacy of Sofosbuvir and Ribavirin in Adults With Recurrent Chronic Hepatitis C Virus (HCV) Post Liver Transplant

Start date: November 2012
Phase: Phase 2
Study type: Interventional

This is an open-label, single-arm study of sofosbuvir (GS-7977) and ribavirin (RBV) in adults who have had a liver transplant which has become re-infected with hepatitis C. The treatment period is 24 weeks with up to 48 weeks of follow up. The total time in this study will last up to 72 weeks not including the screening visit.